EUVIMEDEUVIMED entdecken
Crossref

Biomarkers of Attenuation in the Leishmania donovani Centrin Gene Deleted Cell Line-Requirements for Safety in a Live Vaccine Candidate

Robert Duncan, Ranadhir Dey, Keiko Tomioka, Heather Hairston, Angamuthu Selvapandiyan, Hira L. Nakhasi

The Open Parasitology Journal · 2009

DOI: 10.2174/1874421400903010014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Parasitology Journal, 2009. Verfasst von Robert Duncan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomarkers of the attenuated phenotype are needed to develop live attenuated parasites into safe Leishmania vaccines.The centrin-1 gene deleted strain of Leishmania donovani (LdCEN1 -/-) shows promise as a vaccine candidate.To identify genes whose expression patterns are indicators of attenuation, the LdCEN1 -/-line was compared to wild type by gene expression microarray.Two genes, one coding for a 27kDa protein (p27) and another coding for putative Argininosuccinate Synthase (AS) have such expression patterns.Both genes express a higher RNA level in the amastigote stage than in the promastigote stage of wild type cells; however they are down-regulated in the LdCEN1 -/-amastigote cells.Western blots indicated that the AS protein level is also reduced in the LdCEN1 -/-amastigotes, while the p27 protein level is not reduced even when its mRNA level has diminished.Northern and Western blot analysis with these two biomarkers showed that LdCEN1 -/-parasites recovered after five weeks of infection in mice had the same expression pattern as they had prior to infection and episomal expression of centrin in the LdCEN1 -/-cells restored normal expression of both genes.Measurement of the expression of these two genes in infected macrophages by RT-PCR indicated the same pattern as in cultured cells.Therefore, both the mRNA and/or the protein levels of these two genes could be used as biomarkers of attenuation to monitor the safety of the LdCEN1 -/-cell line as it is developed as a potential vaccine.

Zitieren

APA

Duncan, R., Dey, R., Tomioka, K., Hairston, H., Selvapandiyan, A., & Nakhasi, H. L. (2009). Biomarkers of Attenuation in the Leishmania donovani Centrin Gene Deleted Cell Line-Requirements for Safety in a Live Vaccine Candidate. The Open Parasitology Journal. https://doi.org/10.2174/1874421400903010014

Vancouver

Duncan R, Dey R, Tomioka K, Hairston H, Selvapandiyan A, Nakhasi HL. Biomarkers of Attenuation in the Leishmania donovani Centrin Gene Deleted Cell Line-Requirements for Safety in a Live Vaccine Candidate. The Open Parasitology Journal. 2009. doi:10.2174/1874421400903010014

BibTeX
@article{Duncan2009,
  author = {Duncan, Robert and Dey, Ranadhir and Tomioka, Keiko and Hairston, Heather and Selvapandiyan, Angamuthu and Nakhasi, Hira L.},
  title = {Biomarkers of Attenuation in the Leishmania donovani Centrin Gene Deleted Cell Line-Requirements for Safety in a Live Vaccine Candidate},
  journal = {The Open Parasitology Journal},
  year = {2009},
  doi = {10.2174/1874421400903010014}
}
Kostenlos starten →